Procept Biorobotics Corp (PRCT)

10:26 AM

Redefining Prostate Cancer Care: How PROCEPT BioRobotics' Aquablation Therapy Could Disrupt Urology and Unlock a $10B+ Market - AInvest

10:26 AM

08:00 AM

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy - Stock Titan

08:00 AM

04:07 AM

What analysts say about PROCEPT BioRobotics Corporation stockUnbelievable profit margins - Autocar Professional

04:07 AM

01:28 AM

What drives PROCEPT BioRobotics Corporation stock priceUnmatched market gains - Autocar Professional

01:28 AM

Jul 22, 2025

Is PROCEPT BioRobotics Corporation a good long term investmentMassive portfolio appreciation - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Evaluating PROCEPT BioRobotics (PRCT) Ahead of Q2 2025 Earnings: A Strategic Buy Opportunity in Surgical Robotics? - AInvest

Jul 21, 2025

Jul 21, 2025

Procept Biorobotics shares rise 1.65% after-hours after announcing Q2 2025 earnings report date. - AInvest

Jul 21, 2025

Jul 21, 2025

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times

Jul 21, 2025

Jul 21, 2025

PROCEPT BioRobotics to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Quiver Quantitative

Jul 21, 2025

Jul 21, 2025

PROCEPT BioRobotics Corp (PRCT) stock falls 3.23% on July 21 - AInvest

Jul 21, 2025

Jul 21, 2025

PROCEPT BioRobotics Corporation Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - printweek.in

Jul 21, 2025

Jul 20, 2025

PROCEPT BioRobotics Corp Shares Surge 3.68% Amid Analyst Predictions of 26.35% Upside - AInvest

Jul 20, 2025

Jul 19, 2025

Nisa Investment Advisors LLC Purchases 270 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World

Jul 19, 2025

Jul 18, 2025

Why PROCEPT BioRobotics Corporation stock is on top investor watchlistsExpert Trading Flow - Newser

Jul 18, 2025

Jul 17, 2025

how procept biorobotics corporation stock performs during market volatilityGroup Only Stock Signals - Newser

Jul 17, 2025

Jul 17, 2025

Morgan Stanley Lowers PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $68.00 - Defense World

Jul 17, 2025

Jul 17, 2025

Q2 EPS Estimate for PROCEPT BioRobotics Raised by Analyst - Defense World

Jul 17, 2025

Jul 16, 2025

Positive Outlook on PROCEPT BioRobotics Amid New Fee Schedule Developments for Aquablation - AInvest

Jul 16, 2025

Jul 16, 2025

Procept BioRobotics Receives Favorable CMS Updates and Reimbursement Stability - AInvest

Jul 16, 2025

Jul 16, 2025

Procept BioRobotics says Aquablation therapy assigned a Category I code - MSN

Jul 16, 2025

Jul 16, 2025

A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $68 to $85 - 富途牛牛

Jul 16, 2025

Jul 16, 2025

Teacher Retirement System of Texas Has $646,000 Stock Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World

Jul 16, 2025

Jul 16, 2025

PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 4.7% Following Analyst Downgrade - Defense World

Jul 16, 2025

Jul 16, 2025

How PROCEPT BioRobotics Corporation stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 16, 2025

Jul 15, 2025

Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionPredictable Return Stock Picks - Newser

Jul 15, 2025

Jul 15, 2025

What makes PROCEPT BioRobotics Corporation stock price move sharplyFree Real-Time Trading Opportunities - Newser

Jul 15, 2025

Jul 15, 2025

Procept BioRobotics Awarded Category 1 Code in 2026 Medicare Proposal - MarketScreener

Jul 15, 2025

Jul 15, 2025

Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts By Investing.com - Investing.com South Africa

Jul 15, 2025

Jul 15, 2025

Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts - Investing.com Nigeria

Jul 15, 2025

Jul 14, 2025

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule - Stock Titan

Jul 14, 2025

Jul 14, 2025

Buy Recommendation for Procept BioRobotics Supported by Favorable CMS Updates and Reimbursement Stability - TipRanks

Jul 14, 2025

Jul 14, 2025

PROCEPT BioRobotics Announces Category I CPT Code Assignment for Aquablation Therapy Effective January 1, 2026 - Nasdaq

Jul 14, 2025

Jul 14, 2025

Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛

Jul 14, 2025

Jul 12, 2025

PROCEPT BioRobotics (NASDAQ:PRCT) Rating Lowered to “Sell” at Wall Street Zen - Defense World

Jul 12, 2025

Jul 09, 2025

Procept BioRobotics initiated with an Overweight at Stephens - TipRanks

Jul 09, 2025

Jul 09, 2025

Insiders At PROCEPT BioRobotics Sold US$12m In Stock, Alluding To Potential Weakness - simplywall.st

Jul 09, 2025

Jul 08, 2025

New Analyst Forecast: $PRCT Given 'Perform' Rating - Quiver Quantitative

Jul 08, 2025

Jul 08, 2025

Oppenheimer Initiates PROCEPT BioRobotics(PRCT.US) With Hold Rating - 富途牛牛

Jul 08, 2025